Results 191 to 200 of about 125,690 (294)

A novel variant in MYBPC3 causes hypertrophic cardiomyopathy by haploinsufficiency. [PDF]

PLoS One
Zhang Y, Gong W, Cong Y, Zhang X, Zheng Z.   +4 more
europepmc   +1 more source

Genetic Testing For Hypertrophic Cardiomyopathy

, 2008
Ali J. Marian
openalex   +1 more source

The First Report of Cod Gill Poxvirus in Gills of Atlantic Cod (Gadus morhua L.) Suffering From Cardiorespiratory Disease

Journal of Fish Diseases, Volume 48, Issue 4, April 2025.
ABSTRACT Atlantic cod farming experiences renewed growth in Norway, and increased awareness is essential to address emerging diseases in this species. There are few reports on gill diseases in cod, and to date, no viral gill infections of cod have been documented. In this study, we collected samples from three sequential time points in summer 2023 from
Mona C. Gjessing, Torstein Tengs, Hanne Nilsen, Saima Mohammad, Simon C. Weli   +4 more
wiley   +1 more source

Genetic determinants of the phenotype in a Swedish cohort of patients with hypertrophic cardiomyopathy. [PDF]

Sci Rep
Antheia K, Eva F, Jan-Erik K, Henrik G, Rada E, Cecilia G.   +5 more
europepmc   +1 more source

INFECTIVE ENDOCARDITIS DUE TO GEMELLA-MORBILLORUM COMPLICATING HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY [PDF]

, 1994
Campbell, NP, Kerr, JR, McGimpsey, JG, Webb, CH   +3 more
core   +1 more source

Cardiac fibrosis induced by high‐fat diet in ApoE‐deficient male mice is exacerbated by genetic deletion of PACAP–PAC1 signaling

Journal of Neuroendocrinology, EarlyView.
Abstract Cardiac fibrosis is characterized by an excessive accumulation of extracellular matrix proteins and occurs in a variety of cardiac diseases, such as the highly prevalent syndrome heart failure with preserved ejection fraction (HFpEF) and other cardiac disorders.
J. M. Schubart, M. K. H. Schaefer, G. A. Bonaterra, L. Mey, H. Schwarzbach, S. Pankuweit, F. Ausbuettel, L. E. Eiden, S. Weyand, E. Weihe, R. Kinscherf, C. Waechter   +11 more
wiley   +1 more source

Author Correction: Individualized interactomes for network-based precision medicine in hypertrophic cardiomyopathy with implications for other clinical pathophenotypes

Nature Communications, 2022
Bradley A. Maron, Rui-Sheng Wang, Sergei Shevtsov, Stavros G. Drakos, Elena Arons, Omar Wever-Pinzon, Gordon S. Huggins, Andriy O. Samokhin, William M. Oldham, Yasmine Aguib, Magdi H. Yacoub, Ethan J. Rowin, Barry J. Maron, Martin S. Maron, Joseph Loscalzo   +14 more
doaj   +1 more source

The role of CARMA3 in regulating fibrosis to prevent hypertrophic cardiomyopathy. [PDF]

Cell Death Discov
Liu Y, Chen G, Yao Y, Jiang Y, Wen C, Wang W, Liu Q, Cao Y, Huang F, Chen W, Qiu Z.   +10 more
europepmc   +1 more source

Implications of myocardial bridging on heart rhythm in patients with hypertrophic cardiomyopathy [PDF]

Inês Neves, Mariana Caetano Coelho, Miguel Marques Antunes, P Garcia Bras, A Ferreira, I Cardoso, J Viegas, Inês Almeida, António Fiarresga, Pedro Silva Cunha, Rui Cruz Ferreira, Mário Oliveira, Sílvia Aguiar Rosa   +12 more
openalex   +1 more source

Mortality Trends in Atrial Fibrillation With Cardiomyopathy Among Patients Aged 25 and Older in the United States

Pacing and Clinical Electrophysiology, EarlyView.
ABSTRACT Background Atrial fibrillation (AF) is a prevalent arrhythmia that frequently coexists with cardiomyopathy, leading to deteriorated cardiovascular outcomes. Analyzing the trends associated with these conditions is essential for improving prevention strategies and management practices. Methods CDC WONDER (1999–2023) data were analyzed to assess
Muhammad Abdullah Naveed, Sivaram Neppala, Ahila Ali, Muhammad Omer Rehan, Hamza Naveed, Rabia Iqbal, Bazil Azeem, Mushood Ahmed, Muhammad Zia Khan, Siddharth Agarwal, Himaja Dutt Chigurupati, Nimra Shafi, Yasir Sattar, Zain Ul Abideen Asad, Muhammad Bilal Munir   +14 more
wiley   +1 more source